IP Library Patent Application 12207911
Patent Application
App. No. 12/207,911

POLYHYDROXYALKANOATE NERVE REGENERATION DEVICES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/207,911
Abstract

Nerve regeneration devices are provided with improved rates of axonal regeneration, and methods for their manufacture are also disclosed. The devices are formed from a biocompatible, absorbable polymer, known as poly-4hydroxybutyrate. Growth factors, drugs, or cells that improve nerve regeneration may be incorporated into the devices. The devices are administered by implantation preferably without the use of sutures. In one aspect, the device is in the form of a wrap that can be used easily to capture the severed nerve bundle ends during surgery, and formed into a conduit in situ. If desired, the edges of the wrap can be melted together to seal the conduit, and hold it in place A major advantage of the device is that it does not need to be removed after use since it is slowly degraded and cleared by the patient's body, yet remains functional in situ beyond the time required for nerve regeneration, and helps exclude scar tissue. The device also degrades in a cell-friendly manner, and does not release highly acidic or inflammatory metabolites. Furthermore, the device is flexible, strong, does not crush the regenerating nerve, is easy to handle, reduces surgical time by eliminating the need to harvest an autologous graft, and allows the surgeon to repair the nerve without a prolonged delay.

Claims (14)

1 . A nerve regeneration device comprising a poly-4-hydroxybyrate polymer in the form of a porous conduit.

2 . (canceled)

3 . The device of claim 1 wherein the polymer is poly-4-hydroxybutyrate.

4 . The device of claim 1 wherein the pores of the conduit are greater than 5 μm in diameter.

5 . The device of claim 1 wherein the pores of the conduit are less than 500 μm in diameter.

6 . The device of claim 1 wherein the conduit comprises a material selected from the group consisting of nerve cells, growth factors, and drugs.

7 . A method for preparing a nerve regeneration device comprising a poly-4-hydroxybyrate polymer in the form of a porous conduit wherein the device is prepared by thermally induced phase separation of the polymer in a solvent in combination with salt particles, removing the polymer solvent, and removing the salt particles.

8 . The method of claim 7 comprising leaching with an alcohol followed by leaching with water or a solution comprising a surfactant.

9 . The method of claim 7 wherein the device is prepared by a combination of thermally induced phase separation and poragen leaching.

10 . The method of claim 8 wherein the surfactant is a polysorbate

11 . A method of nerve repair or regeneration comprising providing a nerve regeneration device comprising a poly-4-hydroxybyrate polymer in the form of a wrapped porous conduit.

12 . The method of claim 11 comprising inserting severed nerve ends into the conduit or wrapping the nerve ends with the polymer and sealing it into a conduit.

13 . The method of claim 12 wherein the device is sealed by application of heat.

14 . The method of claim 11 providing an axonal regeneration rate of at least 0.8 mm per day across a 10 mm sciatic nerve gap in an animal or human.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 28, 2017
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: TEPHA, INC.
Reel/Frame 043731/0714 →
SECURITY AGREEMENT Recorded Jun 28, 2010
From: TEPHA, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 024599/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2008
From: TERENGHI, GIORGIO; MOHANNA, PARI-NAZ; MARTIN, DAVID P.
To: TEPHA, INC.
Reel/Frame 021509/0192 →